Newsroom

Dr. Michel Chrétien receives 2015 Wilder-Penfield Prix du Québec

November 12, 2015

Dr. Michel Chrétien recently received the Wilder-Penfield Prix du Québec for outstanding contributions to biomedical research. Dr. Chrétien is known around the world for his prohormone theory and the discovery of pro-protein convertases. Since his group discovered these enzymes in 1990, research in the field has exploded and has led to therapeutically important insights into a number of diseases, including familial hypercholesterolemia, atherosclerosis, cancer and viral infections like SARS, avian flu and HIV.

Dr. Chrétien has played a major leadership role in the Ottawa health research community, especially during his time as CEO and Scientific Director of the Loeb Health Research Institute, predecessor of the Ottawa Hospital Research Institute at the Civic Campus.

Details are available here.

The Ottawa Hospital’s Chrétien Researcher of the Year Award is also named after Dr. Chrétien.

About The Ottawa Hospital


The Ottawa Hospital is one of Canada’s largest learning and research hospitals with over 1,100 beds, approximately 12,000 staff and an annual budget of over $1.2 billion. Our focus on research and learning helps us develop new and innovative ways to treat patients and improve care. As a multi-campus hospital, affiliated with the University of Ottawa, we deliver specialized care to the Eastern Ontario region, but our techniques and research discoveries are adopted around the world. We engage the community at all levels to support our vision for better patient care.

For further information, please contact


Jennifer Ganton
Director, Communications and Public Relations
Ottawa Hospital Research Institute
Office: 613-798-5555 x 73325
Cell: 613-614-5253
jganton@ohri.ca